2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

ASCO 2020 CLL Updates: Should Everyone Get Ibrutinib?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Manali Kamdar
By 2020 ASCO Virtual Direct™ Highlights FEATURING Manali Kamdar
0 views
August 24, 2020
Comments 4
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou
Hematologic Oncology
20:35
2020 ASCO Virtual Direct™ Highlights

ASCO 2020 CLL Updates: Should Everyone Get Ibrutinib?

Feat. M. Kamdar
12:40
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on DLBCL: What Is the Optimal Venetoclax Dosing w/…

Feat. M. Kamdar
04:47
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Indolent Lymphoma: Obinutuzumab + Chemo vs. Ritu…

Feat. M. Kamdar
04:36
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Hodgkin Lymphoma: Is Pembrolizumab a Better Opti…

Feat. M. Kamdar